The brain tumor microenvironment (TME) is emerging as a critical regulator of cancer
progression in primary and metastatic brain malignancies. The unique properties of this …

Worldwide, over 694 million people have been infected with SARS-CoV-2, with an estimated
55–60% of those infected developing COVID-19. Since the beginning of the pandemic in …

Background We aimed to systematically review the evidence on adverse mental health
outcomes in breast cancer survivors (≥ 1 year) compared with women with no history of …

Some cancer therapies damage DNA and cause mutations in both cancerous and healthy
cells. Therapy-induced mutations may underlie some of the long-term and late side effects of …

Combination chemotherapy is widely exploited for enhanced cancer treatment in the clinic.
However, the traditional cocktail administration of combination regimens often suffers from …

Cancer-related cognitive impairment (CRCI) is a frequent side effect experienced by an
increasing number of cancer survivors with a significant impact on their quality of life …

As the population of cancer survivors has grown into the millions, there has been increasing
emphasis on understanding how the late effects of treatment affect survivors' ability to return …

This review summarizes the current literature on cancer-related cognitive impairment (CRCI)
with a focus on prevalence, mechanisms, and possible interventions for CRCI in those who …

Glioblastoma multiforme (GBM) is a devastating tumor of the central nervous system,
currently missing an effective treatment. The therapeutic gold standard consists of surgical …

Answer questions and earn CME/CNE Over the past few decades, a body of research has
emerged confirming what many adult patients with noncentral nervous system cancer have …